ロード中...
Cancer and mTOR inhibitors in kidney transplantation recipients
BACKGROUND: Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. METHODS: In the current study, patients were registered in...
保存先:
| 出版年: | PeerJ |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
PeerJ Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6237112/ https://ncbi.nlm.nih.gov/pubmed/30473931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.5864 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|